Elanco Animal Health Incorporated (ELAN) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2025
Loading P/E history...
ELAN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Elanco Animal Health Incorporated (ELAN) trades at a price-to-earnings ratio of -55.7x, with a stock price of $26.16 and trailing twelve-month earnings per share of $-0.48.
The current P/E is 148% below its 5-year average of 116.9x. Over the past five years, ELAN's P/E has ranged from a low of 14.1x to a high of 305.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ELAN trades at a 351% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, ELAN trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ELAN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ELAN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $47B | 18.5 | 1.54 | +10% | |
| $932M | 148.1 | - | +107% | |
| $2B | 49.3 | 6.60 | +1883%Best | |
| $10B | 27.0 | - | +893% | |
| $2B | 25.3 | - | +419% | |
| $933B | 43.0 | 1.49 | +96% | |
| $151B | 19.5 | - | -4% | |
| $280B | 15.6Lowest | 0.73Best | +8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ELAN Historical P/E Data (2018–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $20.14 | $0.07 | 305.2x | +161% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $14.28 | $0.87 | 16.5x | -86% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $10.50 | $0.74 | 14.1x | -88% |
| FY2024 Q4 | $12.11 | $0.68 | 17.9x | -85% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $14.69 | $0.40 | 36.3x | -69% |
| FY2019 Q4 | $29.45 | $0.19 | 153.8x | +32% | |
| FY2019 Q3 | Mon Sep 30 2019 00:00:00 GM | $26.59 | $0.26 | 103.5x | -11% |
| FY2019 Q2 | Sun Jun 30 2019 00:00:00 GM | $33.80 | $0.39 | 86.7x | -26% |
| FY2019 Q1 | Sun Mar 31 2019 00:00:00 GM | $32.07 | $0.11 | 291.5x | +149% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $31.53 | $0.22 | 143.3x | +23% |
Average P/E for displayed period: 116.9x
Full ELAN Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ELAN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELAN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELAN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonELAN — Frequently Asked Questions
Quick answers to the most common questions about buying ELAN stock.
Is ELAN stock overvalued or undervalued?
ELAN trades at -55.7x P/E, below its 5-year average of 116.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ELAN's valuation compare to peers?
Elanco Animal Health Incorporated P/E of -55.7x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is ELAN's PEG ratio?
ELAN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2025.